When you attend the Game Developers Conference in San Francisco next March, you'll have access to a smorgsbord of fascinating, cutting-edge talks -- including one about how some devs are working with the Food & Drug Administration to get their work approved for medicinal use.
In his GDC 2018 Business & Marketing track talk on "Games as Medicine: FDA Approval Methods", game industry veteran Noah Falstein will speak to the specific challenges of FDA approval as well as more general issues for studios, individuals, and patients in creating the latest generation of games for health.
You want to be there, because you'll learn specifics of three companies that have applied to get their games reviewed in FDA trials, hear the business, technical, creative, and scientific challenges involved in creating and testing this sort of game, and other opportunities for games as medicine that are opening in the near future.
The FDA is expected to approve the first software for prescription use (in treating ADHD) this year, opening new markets for game developers -- but also exposing the industry to more scrutiny. Come hear how to effectively deal with these opportunities and challenges.
And if that's not exactly what you're after, know that lots more great GDC 2018 sessions will be announced in the coming months. For more information about GDC 2018 visit the show's official website, and subscribe to regular updates via Facebook, Twitter, or RSS.
Gamasutra and GDC are sibling organizations under parent UBM Americas